Novo Nordisk (NVO) Stock Falls 27% After FDA Warning on Unreported Semaglutide Adverse Events - Blockonomi

On March 5, the FDA dispatched a warning letter to Novo Nordisk regarding inadequate reporting of adverse events associated with semaglutide, found in Ozempic and Wegovy. • The letter referenced three... [3550 symbols]

Últimos artigos